Isogen Life Science B.V.
Isogen Life Science B.V. is a prominent player in the medical, dental, and hospital equipment and supplies wholesale sector, headquartered in the Netherlands. Established in [year], the company has built a strong reputation for delivering high-quality products across Europe and beyond, serving healthcare providers with reliable and innovative solutions.
Specialising in a wide range of medical and dental supplies, Isogen Life Science distinguishes itself through its commitment to quality and customer service. Its core offerings include surgical instruments, diagnostic devices, and hospital consumables, tailored to meet the evolving needs of healthcare professionals. With notable achievements in supply chain efficiency and product diversity, Isogen Life Science maintains a solid market position as a trusted distributor in the medical industry.
+8 vs industry average
Isogen Life Science B.V.’s score of 36 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Isogen Life Science B.V.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers is among the least carbon-intensive industries
Industry performance
The Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers industry has reduced its overall emissions by 38% since 2018
Reported emissions
No reported emissions data is available for Isogen Life Science B.V. yet.
Isogen Life Science B.V.'s reported carbon emissions
As Isogen Life Science B.V. is a subsidiary and its emissions data is not separately available, its climate commitments are inherited from its parent organisation. The parent organisation has set long-term net-zero targets by 2050 for direct greenhouse gas emissions (Scope 1).
Furthermore, ambitious targets are in place for indirect emissions. Scope 3 emissions are targeted for a reduction of 30% by 2027, 35% by 2030, 45% by 2035, and a significant 90% reduction or reaching net-zero emissions by 2050, all relative to a 2019 baseline. Notably, Scope 3 upstream emissions saw a reduction of 43% in 2025 compared to the 2019 baseline. These commitments align with industry-standard climate terminology and the goal of achieving net-zero emissions.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Isogen Life Science B.V.’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Isogen Life Science B.V.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project